RESOLUTION THERAPEUTICS
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
RESOLUTION THERAPEUTICS
Industry:
Biopharma Biotechnology Life Science
Founded:
2017-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Total Employee:
11+
Status:
Active
Total Funding:
26.6 M GBP
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
AffyImmune Therapeutics
AffyImmune Therapeutics is a biopharmaceutical company developing genetically engineered immune cells to fight cancer.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Helperby Therapeutics
Helperby Therapeutics (Helperby) is a biopharmaceutical company dedicated to developing the next generation of lifesaving antibiotics.
Kither Biotech
Kither Biotech is a pharmaceutical product company that developmens of new drugs to treat chronic inflammatory diseases
Reflection Therapeutics
Reflection Therapeutics is developing cell therapy technology against neuroinflammation across the board.
Current Advisors List
Current Employees Featured
Founder
Investors List
Syncona Partners LLP
Syncona Partners LLP investment in Series A - Resolution Therapeutics
More informations about "Resolution Therapeutics"
Resolution Therapeutics - Crunchbase Company Profile & Funding
Resolution Therapeutics raised £67 million in a funding round, which significantly boosted overall venture capital investment in Scotland for the final quarter of 2024. This funding round also …See details»
Resolution Therapeutics Information - RocketReach
Resolution Therapeutics is a biotechnology company developing macrophage cell therapy to treat inflammatory organ disease. The company was founded following a productive collaboration …See details»
Resolution Therapeutics: Revenue, Worth, Valuation
About Resolution Therapeutics. Resolution Therapeutics is a Biotech related company founded in 2020 and based in Edinburgh with 67 employees an estimated revenue of $14.7M, and. It has …See details»
Resolution Therapeutics Ltd. - Drug pipelines, Patents, Clinical …
Explore Resolution Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 14 news, Technology Platform:CAR-M, Drug:RTX-001(Resolution …See details»
Resolution Therapeutics | Edinburgh Innovation
The success of the collaboration motivated Syncona to invest a further £26.6 million to form Resolution Therapeutics in 2020 and bring the team’s pioneering science to a clinical setting. …See details»
Resolution Therapeutics
About: Resolution Therapeutics is a biotechnology company developing macrophage cell therapy to treat inflammatory organ disease. The company was founded following a productive …See details»
Resolution Therapeutics Announces £63.5 Million Series B …
Oct 3, 2024 Resolution Therapeutics is a clinical-stage biopharmaceutical company focused on unlocking the regenerative potential of macrophage therapy for the treatment of inflammatory …See details»
About us - Resolution Therapeutics
Victor is the VP of Strategy & Operations at Resolution Therapeutics where he leads corporate development, informatics and is the programme manager for RTX001, the company’s lead asset. Victor started his career as a Venture …See details»
Resolution Therapeutics Announces New Clinical and Preclinical …
Nov 11, 2024 About Resolution Therapeutics ... AASLD is the leading organization of scientists and health care professionals committed to preventing and curing liver disease. It fosters …See details»
Resolution Therapeutics - VentureRadar
Resolution Therapeutics is developing macrophage cell therapies to treat diseases characterised by life-threatening inflammatory organ damage. The Company is built upon more than a …See details»
Resolution Therapeutics' macrophage therapy raises $85 million
Oct 3, 2024 Today, Resolution Therapeutics, a clinical-stage biotech company, secured $85 million (£63.5 million) in series B financing to advance its lead product candidate, RTX001, into …See details»
Resolution Therapeutics gets green light from UK for macrophage …
Jun 27, 2024 Resolution Therapeutics spun out from the University of Edinburgh in 2020. Edinburgh University presented data at EASL from its MAcrophage Therapy for Liver Cirrhosis …See details»
Resolution Therapeutics - Funding, Financials, Valuation & Investors
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases. New. Resources. Advanced Search. Start Free Trial . ... How much …See details»
Resolution Therapeutics and CCRM sign collaboration agreement …
About Resolution Resolution Therapeutics is a biotechnology company developing macrophage cell therapies to treat advanced liver disease. The Company is built upon more than a decade …See details»
Resolution in 'game-changing' liver disease research | The Herald
Dec 5, 2024 Earlier this year Resolution announced it had raised £63.5 million in a series B funding round to finance Phase I/II clinical trials of RTX001, an engineered version of a …See details»
Resolution Therapeutics Announces Regenerative Macrophage …
6 days ago Resolution Therapeutics shares key data from two presentations at the American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting in New Orleans, US, May 13 …See details»
Resolution Therapeutics and CCRM sign collaboration ... - OmniaBio
Nov 7, 2022 Resolution Therapeutics is a biotechnology company developing macrophage cell therapies to treat advanced liver disease. The Company is built upon more than a decade of …See details»
Patients - Resolution Therapeutics
Resolution Therapeutics is dedicated to developing Regenerative Macrophage Therapy, a groundbreaking technology with the potential to transform the lives of patients living with …See details»
Resolution Therapeutics and CCRM sign collaboration agreement …
Nov 7, 2022 London, UK and Toronto, Canada, 7 November, 2022 – Resolution Therapeutics Limited (“Resolution”), a biopharmaceutical company developing macrophage cell therapies to …See details»
WHO Resolution: Historic Pandemic Treaty Approved for Global …
5 hours ago Members of the World Health Organization (WHO), who met on May 19 in Committee A of the World Health Assembly, approved a resolution that called for the ad. …See details»